Press Releases

SciTech Patent Art (SPA) announces insights from a study conducted in the emerging area of Theranostics

February 8, 2019

Theranostics is a fourth-generation technology in pharmaceuticals, transitioning from conventional medicine to a contemporary, personalized and precision-oriented medicine. Theranostics is the merger between therapeutics and diagnostics that renders specifically targeted therapy through continuous, precise and accurate diagnostic data. In cancer, for example, Theranostics will open a new era in which nuclear medicine physicians will help patients through the use of radionucleotide probes combined with personalized choice of radiopharmaceuticals and optimum administration plans.

SPA study has revealed that this is a rapidly growing area, where established giants such as Pfizer and Abbott Laboratories could be collaborating with start-ups such as Proteus Digital Health and ReShape Lifesciences. Interestingly, these groups are pursuing different strategies to enter/grow in this market leveraging their current strengths. The start-ups are focusing on development of implantable devices whereas large companies are focusing on capturing precise efficacy data from their digital patient databases to fine-tune treatments. Universities such as Queensland University of Technology and Hong Kong Baptist University are leading in this space with their programs in nanomedicine and multifunctional cyanine compounds.

The authors of this paper note that the excitement in Theranostics is driven by innovations at the interface of many disciplines – chemistry, pharmacology, biology and ICT (information and communication technology) applied at the patient-level. Theranostics holds the potential to make chronic disease treatment significantly cost effective with better efficacy.

SciTech Patent Art (http://www.patent-art.com/) is a leading patent and technology analytics firm based out of Hyderabad, India. With 17 years of experience and over 90 analysts covering various scientific and engineering disciplines, SPA has been providing high quality and cost-effective services to large corporations in the US, Japan, Netherlands, Switzerland and Germany. SPA's scientists, assisted by proprietary Deep Web and AI/ML tools, extract in-depth technology insights from large patent and non-patent data-sets.

Back

Social media

Recent News

Technology Intelligence: Connecting The Dots To Generate Compelling Insights
February 21, 2020
Fostering Fifth-Generation (5G) Mobile Communications With High-Performance Materials
February 21, 2020
Drawing Analyzer from SciTech Patent Art (SPA) Significantly Improves Analyst’s Productivity
February 15, 2020
Virtual Reality – A Game Changer in Healthcare
January 30, 2020
SciTech Patent Art (SPA)’s Patent Prosecution Tracking Tool allows you to track competitive strategic interests
January 29, 2020
SciTech Patent Art (SPA)’s customized news feed engages Deep Web crawling to provide consumer and technology insights
December 19, 2019
Smart shelves: Next-generation retail technology which is being adopted by retailers and consumers
November 13, 2019
Where is the clean label trend going in the food and beverage industry?
October 21, 2019
Early-stage Developers Database for Open Innovation Scouting Teams
September 19, 2019
Enterprise Competitive Technical Intelligence Program to Support Implementation of Corporate Innovation Strategy
July 02, 2019
SciTech Patent Art (SPA) announces insights from a study conducted in the emerging area of Theranostics
February 08, 2019
SciTech Patent Art Launches Technology-Trained AI/ML Agents to Dramatically Improve Analyst Productivity
February 04, 2019